Concepedia

Li Yang

LY

20

Publications

640

Citations

17

H-Index

2006

Active since

Affiliations

Shanghai Institute of Materia Medica(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Shanghai University of Traditional Chinese Medicine

East China Normal University

Li Yang is an author at Shanghai Institute of Materia Medica specializing in medicine, pharmacology, and virology.

ORCID

Top concepts

Publications per year

2006–2022

20

Publications

20

Identification of SARS-CoV-2 entry inhibitors among already approved drugs

Li Yang, Rongjuan Pei, Heng Li et al. · Acta Pharmacologica Sinica · 2020 · 94 citations · Full text

Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus

Yu Luo, Jia‐Ping Yao, Li Yang et al. · Bioorganic & Medicinal Chemistry · 2010 · 55 citations

, , +7

A Novel Pyridazinone Derivative Inhibits Hepatitis B Virus Replication by Inducing Genome-Free Capsid Formation

Yajuan Wang, Dong Lu, Yi-Bin Xu et al. · Antimicrobial Agents and Chemotherapy · 2015 · 53 citations · Full text

Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation

Li Yang, Liping Shi, Haijun Chen et al. · Acta Pharmacologica Sinica · 2014 · 53 citations · Full text

, , +12

Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion

Yi-Bin Xu, Li Yang, Guifeng Wang et al. · Antiviral Research · 2014 · 51 citations

, , +11

Rows per page

1–5 of 20